» Articles » PMID: 27597851

Gel-Trapped Lymphorganogenic Chemokines Trigger Artificial Tertiary Lymphoid Organs and Mount Adaptive Immune Responses In Vivo

Overview
Journal Front Immunol
Date 2016 Sep 7
PMID 27597851
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

We previously generated artificial lymph node-like tertiary lymphoid organs (artTLOs) in mice using lymphotoxin α-expressing stromal cells. Here, we show the construction of transplantable and functional artTLOs by applying soluble factors trapped in slow-releasing gels in the absence of lymphoid tissue organizer stromal cells. The resultant artTLOs were easily removable, transplantable, and were capable of attracting memory B and T cells. Importantly, artTLOs induced a powerful antigen-specific secondary immune response, which was particularly pronounced in immune-compromised hosts. Synthesis of functionally stable immune tissues/organs like those described here may be a first step to eventually develop immune system-based therapeutics. Although much needs to be learned from the precise mechanisms of action, they may offer ways in the future to reestablish immune functions to overcome hitherto untreatable diseases, including severe infection, cancer, autoimmune diseases, and various forms of immune deficiencies, including immune-senescence during aging.

Citing Articles

Initiation of primary T cell-B cell interactions and extrafollicular antibody responses in an organized microphysiological model of the human lymph node.

Zatorski J, Raskovic D, Arneja A, Kiridena S, Ozulumba T, Hammel J bioRxiv. 2025; .

PMID: 39868310 PMC: 11761657. DOI: 10.1101/2025.01.12.632545.


Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer.

Chen W, Zhang L, Gao M, Zhang N, Wang R, Liu Y Front Immunol. 2025; 15():1519034.

PMID: 39840050 PMC: 11747648. DOI: 10.3389/fimmu.2024.1519034.


Artificial Tertiary Lymphoid Structures: Exploring Mesenchymal Stromal Cells as a Platform for Immune Niche Formation.

Zubkova E, Kalinin A, Beloglazova I, Kurilina E, Menshikov M, Parfyonova Y Int J Mol Sci. 2025; 25(24.

PMID: 39769051 PMC: 11676966. DOI: 10.3390/ijms252413286.


B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications.

Wu X, Huang Q, Chen X, Zhang B, Liang J, Zhang B Theranostics. 2025; 15(2):605-631.

PMID: 39744696 PMC: 11671382. DOI: 10.7150/thno.105423.


Tertiary Lymphoid Structures in Microorganism-Related Cancer.

Deng S, Yang X, He L, Hou Y, Meng H Cancers (Basel). 2024; 16(20).

PMID: 39456558 PMC: 11505735. DOI: 10.3390/cancers16203464.


References
1.
Carragher D, Rangel-Moreno J, Randall T . Ectopic lymphoid tissues and local immunity. Semin Immunol. 2008; 20(1):26-42. PMC: 2276727. DOI: 10.1016/j.smim.2007.12.004. View

2.
Kobayashi Y, Watanabe T . Synthesis of artificial lymphoid tissue with immunological function. Trends Immunol. 2010; 31(11):422-8. DOI: 10.1016/j.it.2010.09.002. View

3.
Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti J, Lanzavecchia A . Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004; 304(5667):104-7. DOI: 10.1126/science.1093933. View

4.
Peduto L, Dulauroy S, Lochner M, Spath G, Morales M, Cumano A . Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol. 2009; 182(9):5789-99. DOI: 10.4049/jimmunol.0803974. View

5.
Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K . Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med. 2002; 195(12):1613-24. PMC: 2193565. DOI: 10.1084/jem.20020215. View